Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks

Danaher, the first life sciences stock we’ll look at, is a large-cap leader in the field. This $160 billion company provides a wide range of science and technology services in the fields of biotech and diagnostics in the overall medical and life sciences research sectors. The firm traces its roots back to 1969 and keeps its headquarters in Washington DC, a location that allows management to keep its finger on the pulse of science and biotech policymaking.The Morgan Stanley analyst goes on to up the ante on ...